Adequate bone marrow, cardiac, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXInadequate organ or bone marrow functionXx_NEWLINE_xXAdequate bone marrow, kidney, and liver functionXx_NEWLINE_xXAdequate renal, bone marrow, hepatic, pulmonary, and cardiac functionXx_NEWLINE_xXAdequate bone marrow and organ function, as defined by the protocolXx_NEWLINE_xXAdequate hematological and biological function, confirmed by the following laboratory values within 96 hours prior to enrollment: Bone Marrow FunctionXx_NEWLINE_xXAdequate bone marrow, renal, and liver functionXx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXHas adequate bone marrow, renal and hepatic function based upon laboratory tests as follows:Xx_NEWLINE_xXParticipant has adequate bone marrow, renal, and hepatic function.Xx_NEWLINE_xXAdequate bone marrow, liver and kidney functionXx_NEWLINE_xXInsufficient bone marrow functionXx_NEWLINE_xXAdequate bone marrow reserve as evidenced by:Xx_NEWLINE_xXAdequate bone-marrow, renal and liver function.Xx_NEWLINE_xXAdequate organ and bone marrow function:Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXParticipants have adequate bone marrow, kidney and liver function.Xx_NEWLINE_xXParticipants have adequate bone marrow, renal, hepatic and coagulation function.Xx_NEWLINE_xXAdequate hepatic, renal, and bone marrow function:Xx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate Bone Marrow, Renal, and Liver Function.Xx_NEWLINE_xXMust have adequate bone marrow, liver, and renal function as described in protocolXx_NEWLINE_xXPatients must have adequate bone marrow reserve as evidenced by:Xx_NEWLINE_xXHematologic function: Adequate bone marrow function is defined as:Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXPatients must have adequate bone marrow, hepatic and renal function as defined below:Xx_NEWLINE_xXAdequate bone marrow function, hepatic function, and renal functionXx_NEWLINE_xXParticipant has adequate bone marrow, renal and hepatic function.Xx_NEWLINE_xXAdequate bone marrow, cardiac, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXParticipant has adequate bone marrow and organ function as defined by the following laboratory values:Xx_NEWLINE_xXPatients must have adequate organ and bone marrow function within 14 days prior to registration, as defined below:Xx_NEWLINE_xXAdequate bone marrow function defined by:Xx_NEWLINE_xXAdequate bone marrow reserveXx_NEWLINE_xXAdequate Bone Marrow, Liver, Renal, Pancreatic FunctionXx_NEWLINE_xXPatient with adequate bone marrow reserve, hepatic and renal functionsXx_NEWLINE_xXAdequate Bone Marrow Function.Xx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXAdequate bone marrow function.Xx_NEWLINE_xXHave acceptable bone marrow function defined as:Xx_NEWLINE_xXPatients must have adequate bone marrow, kidney, and liver function, (within 14 days prior to registration), defined as:Xx_NEWLINE_xXSubjects must have adequate Bone Marrow function defined as: For patients without bone marrow involvement: â€¢ Peripheral absolute neutrophil count (ANC) >750/uLXx_NEWLINE_xXAdequate bone marrow, renal, hepatic, and metabolic function (assessed ? 7 days before inclusion in the study):Xx_NEWLINE_xXAdequate organ function within 14 days of study registration including:\r\n* Adequate bone marrow reserve: absolute neutrophil (segmented and bands) count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAdequate bone marrow, liver, renal, and cardiac function at study entry, assessed as follows:Xx_NEWLINE_xXInadequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow, renal and liver functionXx_NEWLINE_xXAdequate bone marrow reserve, liver and renal functionXx_NEWLINE_xXBone marrow, liver and renal functions as assessed by adequate laboratory methods to be conducted within 7 days prior to starting study TreatmentXx_NEWLINE_xXBone marrow function:Xx_NEWLINE_xXAdequate bone marrow and renal functionsXx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate bone marrow function at screeningXx_NEWLINE_xXAdequate organ function defined as: Bone Marrow:Xx_NEWLINE_xXSubject has adequate bone marrow and organ function as shown by:Xx_NEWLINE_xXAdequate bone marrow, liver, and renal function.Xx_NEWLINE_xXAdequate bone marrow, liver, and renal functionXx_NEWLINE_xXAdequate bone marrow, renal, and liver functionXx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXAdequate bone marrow, renal and liver function.Xx_NEWLINE_xXMust have adequate bone marrow, renal, and hepatic function (For the sub-study, the subject must have adequate bone marrow and renal function and have mild-to-moderate hepatic impairment)Xx_NEWLINE_xXAdequate bone marrow (BM), renal, hepatic and metabolic function.Xx_NEWLINE_xXSubject has adequate bone marrow function defined as:Xx_NEWLINE_xXNormal liver, kidney and bone marrow functionXx_NEWLINE_xXParticipants must have adequate bone marrow function, defined as:Xx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXPatients must have adequate organ and bone marrow function within 14 days prior to registration, as defined by: leukocytes >= 2,000/mcLXx_NEWLINE_xXAdequate bone marrow reserve, cardiac, liver, renal and metabolic function:Xx_NEWLINE_xXAssessed by the investigator to have adequate bone marrow function to receive lymphodepleting conditioning chemotherapyXx_NEWLINE_xXSubjects with adequate organ and bone marrow function as defined below:Xx_NEWLINE_xXAdequate bone marrow function within 7 days and defined as:Xx_NEWLINE_xXAdequate marrow, liver, and renal function:Xx_NEWLINE_xXImpaired hepatic or renal function, inadequate bone marrow reserve or organ function, Cardiac dysfunctionXx_NEWLINE_xXPatients must have adequate bone marrow, liver, coagulation and renal function within 7 days prior to study registration, as defined below:Xx_NEWLINE_xXAdequate bone marrow function as evidenced by:Xx_NEWLINE_xXAdequate bone marrow, renal, hepatic, pulmonary, and cardiac functionXx_NEWLINE_xXAdequate organ function and bone marrow reserve as indicated by the following laboratory assessments performed at screening.Xx_NEWLINE_xXAdequate organ and bone marrow functionXx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXParticipants have adequate bone marrow, renal, hepatic and coagulation function.Xx_NEWLINE_xXPatient has adequate bone marrow and organ function as defined by ALL of the following laboratory values (as assessed by local laboratory):Xx_NEWLINE_xXInadequate marrow function in cohort 1:Xx_NEWLINE_xXInadequate marrow function in cohort 2:\r\n* These patients will not have marrow function criteriaXx_NEWLINE_xXPatients must have adequate organ and bone marrow function =< 14 days prior to registration, as defined below:Xx_NEWLINE_xXAdequate bone marrow reservation:Xx_NEWLINE_xXPatients must have adequate bone marrow and organ function.Xx_NEWLINE_xXAssessed by the investigator to have adequate bone marrow function to receive lymphodepleting conditioning chemotherapyXx_NEWLINE_xXNormal organ and bone marrow function defined as:Xx_NEWLINE_xXBone marrow function:Xx_NEWLINE_xXInadequate bone marrow reserve or organ function.Xx_NEWLINE_xXBone marrow, hepatic, and renal function as follows:Xx_NEWLINE_xXAdequate bone marrow function, renal and liver functionsXx_NEWLINE_xXSubject has adequate bone marrow, renal, and hepatic function.Xx_NEWLINE_xXAdequate bone marrow, renal, hepatic, pulmonary, and cardiac function defined as:Xx_NEWLINE_xXAdequate marrow functionXx_NEWLINE_xXAdequate bone marrow, liver and kidney functionXx_NEWLINE_xXNormal bone marrow and organ function as defined below:Xx_NEWLINE_xXAdequate bone marrow function as evidenced by:Xx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate organ and bone marrow function defined by routine testingXx_NEWLINE_xXAdequate Bone Marrow Function:Xx_NEWLINE_xXSubjects must have adequate Bone Marrow function defined as: For patients without bone marrow involvement:Xx_NEWLINE_xXPatients must have adequate bone marrow reserve as evidenced by:Xx_NEWLINE_xXAdequate bone marrow reserves, hepatic function, and renal functionXx_NEWLINE_xXAdequate bone marrow and organ function defined by laboratory valuesXx_NEWLINE_xXAdequate bone marrow, liver, renal and coagulation functionXx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXInadequate bone marrow or organ functionXx_NEWLINE_xXAdequate organ and bone marrow functionXx_NEWLINE_xXMust have adequate bone marrow and renal/hepatic function at the screening and baseline visits, defined as:Xx_NEWLINE_xXAdequate bone marrow, renal and liver function.Xx_NEWLINE_xXAdequate bone marrow function, defined as:Xx_NEWLINE_xXComplete blood count/differential at screening with adequate bone marrow functionXx_NEWLINE_xXAdequate renal, liver and bone marrow function:Xx_NEWLINE_xXHave adequate values, bone marrow, renal and liver functions at screening as defined below:Xx_NEWLINE_xXAdequate bone marrow, hepatic, and renal functionXx_NEWLINE_xXAdequate bone marrow, hepatic, and renal function, as specified in the protocolXx_NEWLINE_xXParticipants must have adequate bone marrow, hepatic and renal functionXx_NEWLINE_xXAdequate bone marrow, hepatic, and renal function, as specified in the protocolXx_NEWLINE_xXAdequate bone marrow, liver and renal functions (tests must be performed within 14 days prior to enrollment).Xx_NEWLINE_xXNormal organ and bone marrow function as defined by:Xx_NEWLINE_xXAdequate bone marrow (BM), renal, hepatic and metabolic function;Xx_NEWLINE_xXAdequate bone marrow, renal and liver function.Xx_NEWLINE_xXAdequate bone marrow, liver, and renal function, as documented by the following laboratory assessments conducted within 28 days prior to dosing:Xx_NEWLINE_xXParticipant has adequate bone marrow, renal, and hepatic function.Xx_NEWLINE_xXAdequate bone marrow and organ function as assessed by the laboratory tests performed within 7 days before of treatment initiation.Xx_NEWLINE_xXAdequate bone marrow, liver and renal function.Xx_NEWLINE_xXAdequate bone marrow, hepatic, and renal functionXx_NEWLINE_xXAdequate bone marrow, renal and hepatic function:Xx_NEWLINE_xXENROLLMENT: Evidence of adequate bone marrow function (defined by absolute neutrophil count >= 750), unless patient has documented tumor metastasis to the bone marrow or other condition that results in cytopenia without abnormal marrow function.Xx_NEWLINE_xXENROLLMENT: Evidence of adequate bone marrow function (defined by platelets >= 50,000), unless patient has documented tumor metastasis to the bone marrow or other condition that results in cytopenia without abnormal marrow function.Xx_NEWLINE_xXPatient has adequate bone marrow, coagulation, liver and renal functionXx_NEWLINE_xXThe subject will have adequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow, liver, kidney functionXx_NEWLINE_xXAdequate bone marrow, kidney, and hepatic function (no laboratory value > 2 times the normal limit)Xx_NEWLINE_xXInadequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXPatients must have adequate heart, kidney, liver and bone marrow function. Patients who have bone marrow disease must still have adequate bone marrow function to enter the study.Xx_NEWLINE_xXPatients must have adequate heart, kidney, liver and bone marrow function.Xx_NEWLINE_xXPatients who have bone marrow disease must still have adequate bone marrow function to enter the study.Xx_NEWLINE_xXAdequate Bone Marrow, Pancreatic Function, Renal Function and Liver Function.Xx_NEWLINE_xXAdequate bone marrow reserve without transfusions defined as:Xx_NEWLINE_xXPatient has adequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXImpaired liver or bone marrow functionXx_NEWLINE_xXBone marrow impairment, renal impairment, liver function abnormality and impaired cardiac function as defined in the protocolXx_NEWLINE_xXParticipant must have adequate bone marrow, renal, and hepatic function.Xx_NEWLINE_xXAdequate organ and bone marrow functionsXx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAdequate organ and bone marrow function determined within 14 days prior to enrollment defined as:Xx_NEWLINE_xXAdequate renal, liver, and bone marrow function according to the following criteria:Xx_NEWLINE_xXPatients must have adequate bone marrow, renal, hepatic, and neurologic functionsXx_NEWLINE_xXImpaired liver or bone marrow functionXx_NEWLINE_xXAdequate liver, bone marrow and renal functionXx_NEWLINE_xXSubject has adequate bone marrow, renal, hepatic and coagulation function.Xx_NEWLINE_xXAdequate bone marrow (BM), renal, hepatic, and metabolic function (assessed ? 14 days before inclusion in the study):Xx_NEWLINE_xXSubjects must have adequate bone marrow, renal and hepatic function and coagulationXx_NEWLINE_xXAdequate hepatic, renal and bone marrow function.Xx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate bone marrow, renal, liver and pancreatic functionXx_NEWLINE_xXAdequate bone marrow, liver, and renal function as assessed by the following laboratory requirements:Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXPatient has adequate bone marrow and organ functionXx_NEWLINE_xXPatient has adequate bone marrow and organ functionXx_NEWLINE_xXBone marrow function:Xx_NEWLINE_xXInadequate bone marrow reserve or organ functionXx_NEWLINE_xXAdequate bone marrow function.Xx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow function, defined as:Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXHave adequate bone marrow and hepatic function.Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXParticipants must have adequate bone marrow, renal and hepatic functionXx_NEWLINE_xXPatients must have adequate organ and bone marrow functionXx_NEWLINE_xXPatients must have adequate organ and bone marrow function within 14 days prior to registration, as defined below:Xx_NEWLINE_xXSubjects must have adequate bone marrow, liver, kidney, and coagulation functions.Xx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXLife expectancy ? 12 weeks. 7. ECOG PS of 0 or 1 8. Adequate organ and bone marrow function 9. Ability to undergo during screening a tumor biopsy that is adequate for biomarker analysis.Xx_NEWLINE_xXParticipant has adequate bone marrow function, evidenced by the following:Xx_NEWLINE_xXAdequate bone marrow function, renal and liver functionsXx_NEWLINE_xXInadequate bone marrow reserve or organ functionXx_NEWLINE_xXAdequate liver, kidney, and bone marrow functionXx_NEWLINE_xXAdequate organ and bone marrow function within the 21 days prior to randomization defined by:Xx_NEWLINE_xXSubject has adequate bone marrow function.Xx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXAdequate bone marrow, liver, and renal functions.Xx_NEWLINE_xXInadequate liver, renal or bone marrow function within 2 weeks of first doseXx_NEWLINE_xXPatient has adequate bone marrow function defined as:Xx_NEWLINE_xXPatients must have adequate bone marrow function, defined asXx_NEWLINE_xXSubject must have adequate bone marrow function at ScreeningXx_NEWLINE_xXInadequate bone marrow, renal, or liver functionXx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXInadequate bone marrow reserve or organ functionXx_NEWLINE_xXSubjects must have adequate bone marrow function as evidenced by:Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow, kidney and liver function.Xx_NEWLINE_xXThe patient has adequate bone marrow function, evidenced by the following:Xx_NEWLINE_xXPerformance Status of 0 or 1 - Adequate bone marrow, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow function documented by:Xx_NEWLINE_xXAssessed by the Investigator to have adequate bone marrow function to receive lymphodepleting chemotherapyXx_NEWLINE_xXAdequate bone marrow, renal, and liver function.Xx_NEWLINE_xXAdequate bone marrow function for participants with solid tumors without known bone marrow involvementXx_NEWLINE_xXAdequate bone marrow function for participants with known bone marrow metastatic diseaseXx_NEWLINE_xXAdequate bone marrow, organ function, cardiac and laboratory parametersXx_NEWLINE_xXAdequate bone marrow function, defined as:Xx_NEWLINE_xXAcceptable bone marrow, renal, and hepatic function based upon screening lab testsXx_NEWLINE_xXAdequate bone marrow, liver and renal function renal functionXx_NEWLINE_xXAdequate bone marrow, liver and renal function as assessed by the following laboratory tests conducted within 7 days before randomization.Xx_NEWLINE_xXAdequate bone marrow, organ function, cardiac and laboratory parametersXx_NEWLINE_xXAdequate bone marrow and hematological function.Xx_NEWLINE_xXPatients must have normal marrow function as defined below:Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXPatient must have normal bone marrow and organ function as defined belowXx_NEWLINE_xXAdequate bone marrow, liver and renal function as assessed within 7 days before starting study treatmentXx_NEWLINE_xXInadequate bone marrow, renal, or hepatic function as defined above, or an active coagulopathy that precludes tissue biopsyXx_NEWLINE_xXAdequate bone marrow reserveXx_NEWLINE_xXSubject must have adequate bone marrow, renal and hepatic function.Xx_NEWLINE_xXE 17. Inadequate organ and bone marrow functionXx_NEWLINE_xXAdequate bone marrow, hepatic, renal and cardiac functionXx_NEWLINE_xXAdequate organ function (bone marrow, kidney and liver)Xx_NEWLINE_xXHave adequate organ and bone marrow function.Xx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXSubjects must have normal organ and bone marrow function measured within 28 days prior to administration of study treatment;Xx_NEWLINE_xXAcceptable bone marrow and organ function at screening;Xx_NEWLINE_xXAdequate hepatic, renal, and bone marrow functionXx_NEWLINE_xXPatients with adequate bone marrow, renal and hepatic function:Xx_NEWLINE_xXAdequate bone marrow independent of growth factor support, renal and hepatic function per defined laboratory criteriaXx_NEWLINE_xXAdequate bone marrow reserve, hepatic and renal functionXx_NEWLINE_xXAdequate Bone Marrow, Renal and liver Functions.Xx_NEWLINE_xXAdequate liver, kidney, and bone marrow functionXx_NEWLINE_xXParticipants must have adequate liver, kidney, and bone morrow functionXx_NEWLINE_xXAdequate bone marrow, renal and liver function.Xx_NEWLINE_xXAdequate bone marrow function.Xx_NEWLINE_xXAdequate glucose control, bone marrow, kidney, liver, and heart function.Xx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXAdequate bone marrow, renal, and hepatic function.Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow function without transfusion or growth factor support, defined as:Xx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXAdequate organ and bone marrow functionsXx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXInadequate renal, hepatic or bone marrow functionXx_NEWLINE_xXAdequate bone marrow, hepatic and renal function as evidenced by:Xx_NEWLINE_xXAdequate bone marrow, renal, liver, cardiac and pulmonary function.Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXHave adequate bone marrow function, liver function, and renal function, as measured by the following laboratory assessments conducted within 7 days prior to the initiation of study treatment:Xx_NEWLINE_xXAdequate bone marrow, kidney, liver, and heart function.Xx_NEWLINE_xXAdequate bone marrow function and organ functionXx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow, renal capacity and hepatic functionXx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXHas adequate bone marrow reserve as evidenced by:Xx_NEWLINE_xXAdequate bone marrow, liver, and renal functionXx_NEWLINE_xXPatient has adequate bone marrow and organ function.Xx_NEWLINE_xXAdequate bone marrow function, defined as:Xx_NEWLINE_xXAdequate bone marrow, liver, and renal functionsXx_NEWLINE_xXAdequate bone marrow, liver, and renal functions, defined as:Xx_NEWLINE_xXAdequate bone morrow and kidney functionXx_NEWLINE_xXAdequate bone marrow, liver, cardiac, and renal functionXx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow, renal, hepatic, and metabolic functionXx_NEWLINE_xXImpaired bone marrow, liver or renal function (as defined by protocol)Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAcceptable bone marrow, liver and kidney function.Xx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow, hepatic, and renal function tests within 30 days prior to enrollment:Xx_NEWLINE_xXAdequate bone and marrow function as defined below:Xx_NEWLINE_xXInadequate organ and bone marrow function as evidenced by:Xx_NEWLINE_xXAdequate organ and bone marrow functions.Xx_NEWLINE_xXInadequate bone marrow, liver, and renal function, as assessed by the following laboratory parameters:Xx_NEWLINE_xXInadequate bone marrow or other organ function (excluding hepatic impairment per eligibility criteria).Xx_NEWLINE_xXAdequate bone marrow, renal and liver functioningXx_NEWLINE_xXAdequate bone marrow and renal functionXx_NEWLINE_xXAdequate bone marrow, renal and liver functionXx_NEWLINE_xXAdequate bone marrow, kidney, and liver functionXx_NEWLINE_xXHave adequate bone marrow reserve and organ function at screening as follows:Xx_NEWLINE_xXAdequate bone marrow, liver and renal function as assessed by the following laboratory requirements conducted within 7 days of starting the study treatment:Xx_NEWLINE_xXAdequate bone marrow, liver, and renal functions as assessed by laboratory analysis to be conducted within 7 days prior to the first dose of study drugXx_NEWLINE_xXPatient has adequate organ and bone marrow functions:Xx_NEWLINE_xXHas adequate organ function (bone marrow, kidney and liver)Xx_NEWLINE_xXBone marrow, liver and renal functions as assessed by adequate laboratory methods to be conducted within 7 days prior to starting study treatmentXx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXAdequate bone marrow, hepatic and renal function as evidenced by:Xx_NEWLINE_xXAdequate bone marrow, and liver function as assessed by the following laboratory requirements conducted within 7 days of starting the study treatmentXx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXProtocol-defined renal , liver and bone marrow functionXx_NEWLINE_xXAdequate bone marrow, hepatic, renal and cardiac functionXx_NEWLINE_xXHave adequate cardiac, bone marrow, liver and kidney functionXx_NEWLINE_xXAdequate bone marrow function as defined as:Xx_NEWLINE_xXPatient has adequate bone marrow and organ function.Xx_NEWLINE_xXAdequate bone marrow, liver, and renal functionXx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow functionXx_NEWLINE_xXAdequate organ or bone marrow functionXx_NEWLINE_xXParticipants with solid tumors (with the exception of neuroblastoma) must have adequate bone marrow function in Part 1.Xx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXPatient has adequate bone marrow and organ functionXx_NEWLINE_xXAdequate bone marrow function, defined as:Xx_NEWLINE_xXPatient has adequate bone marrow reserve, as evidenced by:Xx_NEWLINE_xXAdequate organ and bone marrow functionXx_NEWLINE_xXAdequate bone marrow, renal and liver function as defined in the protocol.Xx_NEWLINE_xXThe participant has adequate bone marrow reserve, and renal and hepatic functionXx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXAdequate organ and bone marrow function as assessed by laboratory testsXx_NEWLINE_xXAdequate bone marrow function.Xx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXAdequate bone marrow reserve as defined per protocol;Xx_NEWLINE_xXHave adequate bone marrow reserve defined as:Xx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate bone marrow and organ functionXx_NEWLINE_xXAdequate bone marrow and organ function as determined by the consenting/enrolling investigatorXx_NEWLINE_xXAdequate bone marrow, liver, and renal function, as assessed by the following requirements conducted within 21 days prior to dosing:Xx_NEWLINE_xXAdequate bone marrow, liver, and renal functionsXx_NEWLINE_xXParticipant has adequate bone marrow, renal, hepatic and cardiac function.Xx_NEWLINE_xXAdequate bone marrow, renal, and hepatic function.Xx_NEWLINE_xXAdequate bone marrow, liver, cardiac, and renal functionXx_NEWLINE_xXAdequate bone marrow, liver, and renal functionXx_NEWLINE_xXAdequate bone marrow, liver and kidney functionXx_NEWLINE_xXPatients must have adequate bone marrow, renal, hepatic, and sensory neurologic function to be eligible to receive platinum/taxane-based chemotherapyXx_NEWLINE_xXAdequate bone marrow reserveXx_NEWLINE_xXAdequate bone marrow reserves and liver and kidney function, as assessed by the following laboratory requirements:Xx_NEWLINE_xXHave adequate bone marrow reserves and liver and kidney function, as assessed by the following laboratory requirements:Xx_NEWLINE_xXInadequate bone marrow functionXx_NEWLINE_xXAdequate bone marrow, liver and renal functionXx_NEWLINE_xXAdequate bone marrow function as evidenced by:Xx_NEWLINE_xXPatients must have adequate organ and bone marrow function 10 days prior to registration, as defined below:Xx_NEWLINE_xXAdequate bone marrow and organ function as defined as:Xx_NEWLINE_xXAdequate bone marrow, liver, and kidney function within 2 weeks prior to first doseXx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate bone marrow, renal, hepatic, and blood clotting functionXx_NEWLINE_xXAdequate organ function for patients receiving crizotinib therapy as defined by the following criteria: Bone marrow functionXx_NEWLINE_xXAdequate bone marrow, renal, hepatic, and metabolic function (assessed ? 7 days before inclusion in the study):Xx_NEWLINE_xXAdequate organ functions (kidney, liver, cardiac, bone marrow).Xx_NEWLINE_xXPatients must have normal marrow function as defined:Xx_NEWLINE_xXAdequate bone marrow reserve and renal and hepatic function within 28 days before the first dose of study drug on the basis of the defined laboratory parameters.Xx_NEWLINE_xXAdequate organ and bone marrow functionXx_NEWLINE_xXAdequate organ and bone marrow functionXx_NEWLINE_xXAdequate function of bone marrow:Xx_NEWLINE_xXAdequate bone marrow, liver, and renal functions as assessed by the following laboratory requirements to be conducted within 7 days prior to the first dose of study drug:Xx_NEWLINE_xXAdequate bone marrow function:Xx_NEWLINE_xXAdequate bone marrow, kidney and liver functionXx_NEWLINE_xXAdequate bone marrow, liver, and renal functionXx_NEWLINE_xX